Episode 126: Oncology Clinical Trials and Drug Development
Oct 23, 2020•38 min•Season 1Ep. 126
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
ONS member Moe Schwartz, PharmD, BCOP, professor of pharmacy practice in the James L. Winkle College of Pharmacy at the University of Cincinnati in Ohio, ONS associate member, and member of the Cincinnati Tri-State ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss cancer drug trials, U.S. Food and Drug Administration (FDA) approvals in 2020, and what oncology nurses need to know about the process for oncology drug development. The advertising messages in this episode are sponsored by the University of Cincinnati Online.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
Episode Notes
Check out these resources from today's episode:
- Read the latest FDA updates on ONS Voice.
- Oncology Nursing Podcast Episode 19: The Practical Side of Clinical Trials
- Clinical Journal of Oncology Nursing article: Clinical Trials: Understanding Patient Perspectives and Beliefs About Treatment
- ONS book: Manual for Clinical Trials Nursing (third edition)
- ONS's Oncology Clinical Trials Nurse Competencies
- ONS webinar: Offering Clinical Trials Can Make a Difference
- Clinicaltrials.gov
- DailyMed
For the best experience, listen in Metacast app for iOS or Android